Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

China Pharma Holdings Debt to Equity Ratio 2010-2023 | CPHI

Current and historical debt to equity ratio values for China Pharma Holdings (CPHI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. China Pharma Holdings debt/equity for the three months ending December 31, 2023 was 0.19.
  
China Pharma Holdings Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2023-12-31 $0.01B $0.01B 1.21
2023-09-30 $0.01B $0.01B 1.51
2023-06-30 $0.01B $0.00B 2.61
2023-03-31 $0.01B $0.01B 2.72
2022-12-31 $0.01B $0.00B 3.15
2022-09-30 $0.01B $0.00B 4.72
2022-06-30 $0.01B $0.00B 3.45
2022-03-31 $0.02B $0.01B 2.94
2021-12-31 $0.02B $0.01B 2.76
2021-09-30 $0.01B $0.01B 1.65
2021-06-30 $0.01B $0.01B 2.06
2021-03-31 $0.01B $0.01B 1.77
2020-12-31 $0.01B $0.01B 1.64
2020-09-30 $0.01B $0.01B 1.69
2020-06-30 $0.02B $0.01B 1.76
2020-03-31 $0.01B $0.01B 1.68
2019-12-31 $0.01B $0.01B 1.41
2019-09-30 $0.01B $0.03B 0.46
2019-06-30 $0.01B $0.03B 0.49
2019-03-31 $0.02B $0.03B 0.48
2018-12-31 $0.02B $0.03B 0.50
2018-09-30 $0.02B $0.04B 0.40
2018-06-30 $0.02B $0.04B 0.42
2018-03-31 $0.02B $0.04B 0.40
2017-12-31 $0.02B $0.04B 0.39
2017-09-30 $0.02B $0.06B 0.32
2017-06-30 $0.02B $0.06B 0.35
2017-03-31 $0.02B $0.06B 0.34
2016-12-31 $0.02B $0.06B 0.33
2016-09-30 $0.02B $0.07B 0.35
2016-06-30 $0.03B $0.07B 0.37
2016-03-31 $0.03B $0.07B 0.36
2015-12-31 $0.02B $0.07B 0.33
2015-09-30 $0.03B $0.08B 0.35
2015-06-30 $0.03B $0.10B 0.28
2015-03-31 $0.03B $0.09B 0.33
2014-12-31 $0.03B $0.09B 0.31
2014-09-30 $0.03B $0.12B 0.23
2014-06-30 $0.03B $0.12B 0.21
2014-03-31 $0.03B $0.13B 0.19
2013-12-31 $0.03B $0.13B 0.19
2013-09-30 $0.02B $0.14B 0.14
2013-06-30 $0.02B $0.14B 0.10
2013-03-31 $0.01B $0.15B 0.09
2012-12-31 $0.02B $0.15B 0.10
2012-09-30 $0.02B $0.15B 0.11
2012-06-30 $0.02B $0.15B 0.11
2012-03-31 $0.02B $0.15B 0.12
2011-12-31 $0.01B $0.14B 0.10
2011-09-30 $0.01B $0.14B 0.10
2011-06-30 $0.01B $0.13B 0.10
2011-03-31 $0.01B $0.12B 0.11
2010-12-31 $0.01B $0.12B 0.12
2010-09-30 $0.01B $0.11B 0.10
2010-06-30 $0.01B $0.10B 0.12
2010-03-31 $0.01B $0.10B 0.11
2009-12-31 $0.01B $0.09B 0.15
2009-09-30 $0.01B $0.09B 0.12
2009-06-30 $0.01B $0.08B 0.10
2009-03-31 $0.01B $0.07B 0.09
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $0.005B $0.007B
CHINA PHARMA HOLDINGS, Inc. develops, manufactures, and markets generic and brand bio-pharmaceutical products in China that treat a wide range of conditions, including infections, hepatitis, cardiovascular and CNS diseases, and other prevailing diseases. Helpson Bio-pharmaceutical Co., Ltd. (Helpson), a specialty pharmaceutical company headquartered in Haikou City, Hainan province in China, is a wholly owned subsidiary of China Pharma Holdings.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $15.751B 5.69
Dr Reddy's Laboratories (RDY) India $12.261B 19.39
Aspen Pharmacare (APNHY) South Africa $5.328B 0.00
BridgeBio Pharma (BBIO) United States $4.794B 0.00
Bausch Health Cos (BHC) Canada $3.201B 2.50
Amphastar Pharmaceuticals (AMPH) United States $2.016B 13.80
Supernus Pharmaceuticals (SUPN) United States $1.655B 0.00
Taysha Gene Therapies (TSHA) United States $0.454B 0.00
Generation Bio (GBIO) United States $0.188B 0.00
Personalis (PSNL) United States $0.074B 0.00
Assembly Biosciences (ASMB) United States $0.068B 0.00
Acasti Pharma (ACST) Canada $0.026B 0.00
Sol-Gel Technologies (SLGL) Israel $0.020B 0.00
Evoke Pharma (EVOK) United States $0.004B 0.00
Teligent (TLGT) United States $0.000B 0.00